Combined Pulmonary Fibrosis and Emphysema

Abstract

Combined pulmonary fibrosis and emphysema (CPFE) is a clinical entity characterized by the combination of upper lobe emphysema and lower lobe fibrosis, the latter owing to various interstitial lung diseases. These patients have a characteristic lung function profile, with relatively preserved dynamic and static lung volumes, contrasting with a significant reduction of carbon monoxide transfer. The pathogenic mechanisms leading to the coexistence of emphysema with fibrosis remain unclear and different theories have been proposed. CPFE is frequently complicated by pulmonary hypertension, acute exacerbations, and lung cancer leading to poor natural history and prognosis. The syndrome of CPFE represents a distinct pulmonary manifestation in the spectrum of lung diseases associated with connective tissue diseases. Currently, there are no established recommendations regarding the management of patients with CPFE. We provide a review on the existing knowledge of CPFE regarding the epidemiology, pathogenesis, clinical manifestations, radiologic appearance, complications, prognosis, and possible treatment options.

Keywords

emphysema - fibrosis - syndrome - pulmonary hypertension - prognosis

• References

• 1 Singh D, Agusti A, Anzueto A. et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J 2019; 53 (05) 18
• 2 Raghu G, Remy-Jardin M, Myers JL. , et al; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018; 198 (05) e44-e68
• 3 Auerbach O, Garfinkel L, Hammond EC. Relation of smoking and age to findings in lung parenchyma: a microscopic study. Chest 1974; 65 (01) 29-35
• 4 Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 1990; 84 (05) 365-369
• 5 Wells AU, King AD, Rubens MB, Cramer D, du Bois RM, Hansell DM. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med 1997; 155 (04) 1367-1375
• 6 Cottin V, Nunes H, Brillet PY. , et al; Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26 (04) 586-593
• 7 Cottin V, Cordier JF. Combined pulmonary fibrosis and emphysema in connective tissue disease. Curr Opin Pulm Med 2012; 18 (05) 418-427
• 8 Alsumrain M, De Giacomi F, Nasim F. , et al. Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: characterization of presenting lung fibrosis and implications for survival. Respir Med 2019; 146: 106-112
• 9 Lai RS, Chen CF, Chu KA, Lin MH. The effect of emphysema on survival in patients with idiopathic pulmonary fibrosis: a retrospective study in Taiwan. J Chin Med Assoc 2019; 82 (12) 922-928
• 10 Champtiaux N, Cottin V, Chassagnon G. , et al. Combined pulmonary fibrosis and emphysema in systemic sclerosis: a syndrome associated with heavy morbidity and mortality. Semin Arthritis Rheum 2019; 49 (01) 98-104
• 11 Fisher JH, Kolb M, Algamdi M. , et al. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis. BMC Pulm Med 2019; 19 (01) 223
• 12 Schwarzkopf L, Witt S, Waelscher J, Polke M, Kreuter M. Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis. Respir Res 2018; 19 (01) 73
• 13 Margaritopoulos GA, Antoniou KM, Wells AU. Comorbidities in interstitial lung diseases. Eur Respir Rev 2017; 26 (143) 143
• 14 Chae KJ, Jin GY, Han YM. , et al. Prevalence and progression of combined pulmonary fibrosis and emphysema in asymptomatic smokers: a case-control study. Eur Radiol 2015; 25 (08) 2326-2334
• 15 Lederer DJ, Enright PL, Kawut SM. , et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med 2009; 180 (05) 407-414
• 16 Dias OM, Baldi BG, Costa AN, Carvalho CR. Combined pulmonary fibrosis and emphysema: an increasingly recognized condition. J Bras Pneumol 2014; 40 (03) 304-312
• 17 Margaritopoulos GA, Vasarmidi E, Jacob J, Wells AU, Antoniou KM. Smoking and interstitial lung diseases. Eur Respir Rev 2015; 24 (137) 428-435
• 18 Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 2010; 41 (03) 316-325
• 19 Rogliani P, Mura M, Mattia P. , et al. HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med 2008; 102 (12) 1753-1761
• 20 Cronkhite JT, Xing C, Raghu G. , et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 178 (07) 729-737
• 21 Tzouvelekis A, Zacharis G, Oikonomou A. , et al. Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema. BMC Pulm Med 2013; 13: 31
• 22 Malli F, Papakosta D, Antoniou K. , et al. Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort. ERJ Open Res 2019; 5 (01) 00014-02018
• 23 Zhang L, Zhang C, Dong F. , et al. Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis. BMC Pulm Med 2016; 16 (01) 137
• 24 Costa CM, Neder JA, Verrastro CG. , et al. Uncovering the mechanisms of exertional dyspnoea in combined pulmonary fibrosis and emphysema. Eur Respir J 2020; 55 (01) 1901319
• 25 Kitaguchi Y, Fujimoto K, Hanaoka M, Honda T, Hotta J, Hirayama J. Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction. Int J Chron Obstruct Pulmon Dis 2014; 9: 805-811
• 26 Jankowich MD, Rounds S. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung 2010; 188 (05) 365-373
• 27 Cottin V, Hansell DM, Sverzellati N. , et al. Effect of emphysema extent on serial lung function in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2017; 196 (09) 1162-1171
• 28 Ciccarese F, Attinΰ D, Zompatori M. Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know. Radiol Med (Torino) 2016; 121 (07) 564-572
• 29 Kinoshita Y, Watanabe K, Ishii H, Kushima H, Fujita M, Nabeshima K. Distribution of emphysema and fibrosis in idiopathic pulmonary fibrosis with coexisting emphysema. Histopathology 2019; 74 (07) 1103-1108
• 30 Matsuoka S, Yamashiro T, Matsushita S. , et al. Morphological disease progression of combined pulmonary fibrosis and emphysema: comparison with emphysema alone and pulmonary fibrosis alone. J Comput Assist Tomogr 2015; 39 (02) 153-159
• 31 Ando K, Sekiya M, Tobino K, Takahashi K. Relationship between quantitative CT metrics and pulmonary function in combined pulmonary fibrosis and emphysema. Lung 2013; 191 (06) 585-591
• 32 Choi SH, Lee HY, Lee KS. , et al. The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE). PLoS One 2014; 9 (09) e107476
• 33 Jiang CG, Fu Q, Zheng CM. Prognosis of combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis alone. Ther Adv Respir Dis 2019; 13: 1-7
• 34 Sugino K, Ota H, Fukasawa Y, Uekusa T, Homma S. Pathological characteristics in idiopathic nonspecific interstitial pneumonia with emphysema and pulmonary hypertension. Respirol Case Rep 2013; 1 (02) 39-42
• 35 Kishaba T, Shimaoka Y, Fukuyama H. , et al. A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema. BMJ Open 2012; 2 (03) e000988
• 36 Jacob J, Bartholmai BJ, Rajagopalan S. , et al. Predicting outcomes in idiopathic pulmonary fibrosis using automated computed tomographic analysis. Am J Respir Crit Care Med 2018; 198 (06) 767-776
• 37 Goldin JG. Predicting outcome in idiopathic pulmonary fibrosis using automated CT analysis. Am J Respir Crit Care Med 2018; 198 (06) 701-702
• 38 Yoo H, Jeong BH, Chung MJ, Lee KS, Kwon OJ, Chung MP. Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study. BMC Pulm Med 2019; 19 (01) 149
• 39 Koo HJ, Do KH, Lee JB, Alblushi S, Lee SM. Lung cancer in combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis. PLoS One 2016; 11 (09) e0161437
• 40 Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010; 15 (02) 265-271
• 41 Li C, Wu W, Chen N. , et al. Clinical characteristics and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis of 13 studies. J Thorac Dis 2017; 9 (12) 5322-5334
• 42 Moon SW, Park MS, Kim YS. , et al. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation. BMC Pulm Med 2019; 19 (01) 177
• 43 Oh JY, Lee YS, Min KH. , et al. Presence of lung cancer and high gender, age, and physiology score as predictors of acute exacerbation in combined pulmonary fibrosis and emphysema: a retrospective study. Medicine (Baltimore) 2018; 97 (31) e11683
• 44 Fujiwara A, Tsushima K, Sugiyama S. , et al. Histological types and localizations of lung cancers in patients with combined pulmonary fibrosis and emphysema. Thorac Cancer 2013; 4 (04) 354-360
• 45 Gao L, Xie S, Liu H. , et al. Lung cancer in patients with pulmonary fibrosis revisited with the 2015 World Health Organization classification of lung tumors. Clin Respir J 2018; 12: 652-658
• 46 Nathan SD, Barbera JA, Gaine SP. , et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J 2019; 53 (01) 53
• 47 Cottin V, Le Pavec J, Prévot G. , et al; GERM“O”P. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35 (01) 105-111
• 48 Mejía M, Carrillo G, Rojas-Serrano J. , et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136 (01) 10-15
• 49 Collard HR, Moore BB, Flaherty KR. , et al; Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007; 176 (07) 636-643
• 50 Antoniou KM, Margaritopoulos GA, Goh NS. , et al. Combined pulmonary fibrosis and emphysema in scleroderma lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension. Arthritis Rheumatol 2016; 68 (04) 1004-1012
• 51 Yamakawa H, Takemura T, Iwasawa T. , et al. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?. BMC Pulm Med 2018; 18 (01) 25
• 52 Ariani A, Silva M, Bravi E. , et al. Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis. RMD Open 2019; 5 (01) e000820
• 53 Cottin V. Clinical case: combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management. BMC Res Notes 2013; 6 (Suppl. 01) S2
• 54 Flaherty KR, Brown KK, Wells AU. Design of the PF-ILD trial: a double blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. BMJ Open Resp Res 2017; 4 (01) e000212
• 55 Antoniou KM, Bibaki E, Margaritopoulos GA. Controversies in fibrosis and emphysema. Arch Bronconeumol 2017; 53 (05) 231-232
• 56 Oldham JM, Collard HR. Comorbid conditions in idiopathic pulmonary fibrosis: recognition and management. Front Med (Lausanne) 2017; 4: 123
• 57 Jankowich MD, Rounds SIS. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest 2012; 141 (01) 222-231